IDH2 p.R172G

Biomarker type: Somatic variant

Gene context: IDH2

HGVS.p: NP_002159.2:p.Arg172Gly

Precision oncology relationships for therapeutic response involving this biomarker.

Organizations	Biomarkers	Cancer types	Therapies
FDA (1)	IDH2 p.R172G	Acute Myeloid Leukemia	Enasidenib
FDA (1) HC (1)	IDH2 p.R172G	Astrocytoma	Vorasidenib
FDA (1) HC (1)	IDH2 p.R172G	Oligodendroglioma	Vorasidenib